Buy & Sell Boston Beer Company Inc (SAM) – Boston Beer Company Inc Price Today
Aura AI Summary
Key Stats
- $1.89BMarket Cap
- Consumer StaplesSector
- -30.08%3M Drawdown
- $1.76BEnterprise Value
- -Dividend Yield
- 55 daysTypical Hold Time
Boston Beer Company Inc (SAM) is currently valued at a market capitalization of $1.89B, with an enterprise value of $1.76B. Over the past 52 weeks, Boston Beer Company Inc has traded between a low of $180.18 and a high of $260.05, highlighting its annual price range. Over the past three months, Boston Beer Company Inc has recorded a drawdown of -30.08%, reflecting recent price volatility. On average, investors hold Boston Beer Company Inc for approximately 55 days, indicating typical investor behavior on the platform.
About Boston Beer Company Inc
Boston Beer is a leader in U.S. high-end malt beverages and adjacent categories, with strong positions in craft beer, hard cider, and hard seltzer. The firm sells an array of flavor variants and package sizes, predominantly centered around four priority brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly Hard Seltzer. Its drinks are produced in both company-owned breweries as well as through third-party contract arrangements, and while the company primarily goes to market through independent wholesalers (as mandated by law), it operates a fairly large salesforce to induce demand across the value chain (distributors, retailers, and drinkers). The preponderance of revenue is generated domestically.
Most Recent News
Megan Holdings receives Nasdaq notice for falling below $1 minimum bid price, must regain compliance by Nov 2026.
Megan Holdings Limited announced it received a Nasdaq notification for not meeting the minimum bid price of $1 per share, with its shares trading below this threshold for 30 consecutive business days. The company has 180 days, until November 9, 2026,...
Absci insider buys shares amid financial challenges and positive clinical trial progress
A director at Absci purchased 37,453 shares, showing confidence despite the company's Q1 2026 revenue missing estimates by 90%. Absci reported a smaller-than-expected loss and progress in its ABS-201 clinical trial with positive safety data. The insi...
Investors can join Peabody Energy fraud probe over delayed mine production claims.
The Schall Law Firm is investigating Peabody Energy Corporation for potentially misleading investors about the progress of its Centurion mine. Peabody had claimed the mine was ahead of schedule but later disclosed delays in its Q1 2026 earnings repor...